Advanced Medical Solutions Group (AMS) Share Price, News & Analysis

Company Overview

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.

Key Stats

• Today's Range: 195.60 to 214
• 50-Day Range: 176.60 to 237
• 52-Week Range: 168.40 to 275.83
• Volume: 1.91 million shs
• Average Volume: 1.13 million shs
• Market Capitalization: £441.57 million
• P/E Ratio: 39.63
• Dividend Yield: 0.98%
• Price Target: GBX 300
• Consensus Rating: Buy

Advanced Medical Solutions Group Stock Analysis - MarketRank™

Advanced Medical Solutions Group scored higher than 40% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Advanced Medical Solutions Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Advanced Medical Solutions Group has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Advanced Medical Solutions Group is 39.63, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.98.

Price to Earnings Ratio vs. Sector

The P/E ratio of Advanced Medical Solutions Group is 39.63, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.81.

Price to Earnings Growth Ratio

Advanced Medical Solutions Group has a PEG Ratio of 5.00. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Advanced Medical Solutions Group has a P/B Ratio of 1.80. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for AMS.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Advanced Medical Solutions Group pays a meaningful dividend of 1.07%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Advanced Medical Solutions Group does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Advanced Medical Solutions Group is 38.76%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for AMS.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: N/A

News Sentiment

Advanced Medical Solutions Group has a news sentiment score of 0.80. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Advanced Medical Solutions Group this week, compared to 1 article on an average week.

Search Interest

2 people have searched for AMS on MarketBeat in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Advanced Medical Solutions Group insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 3.12% of the stock of Advanced Medical Solutions Group is held by insiders.

Percentage Held by Institutions

58.24% of the stock of Advanced Medical Solutions Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

AMS Stock Analysis - Frequently Asked Questions

How have AMS shares performed this year?

Advanced Medical Solutions Group's stock was trading at GBX 197.60 at the beginning of 2025. Since then, AMS stock has increased by 3.5% and is now trading at GBX 204.50.
View the best growth stocks for 2025 here.

How were Advanced Medical Solutions Group's earnings last quarter?

Advanced Medical Solutions Group plc (LON:AMS) announced its earnings results on Thursday, March, 20th. The company reported $10.65 EPS for the quarter. Advanced Medical Solutions Group had a net margin of 8.49% and a trailing twelve-month return on equity of 4.57%.

How do I buy shares of Advanced Medical Solutions Group?

Shares of AMS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Advanced Medical Solutions Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Advanced Medical Solutions Group investors own include Hawkins (HWKN), Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Athabasca Oil (ATH), AutoZone (AZO), Chipotle Mexican Grill (CMG) and Micron Technology (MU).

Company Calendar

• Last Earnings: 3/20/2025
• Today: 5/04/2025
• Record date for 6/20 Dividend: 5/29/2025
• Ex-Dividend for 6/20 Dividend: 5/29/2025
• Dividend Payable: 6/20/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: Healthcare
• Current Symbol: LON:AMS
• CIK: N/A
• Web: www.admedsol.com
• Phone: +44-1606-863500
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: GBX 300
• High Stock Price Target: GBX 300
• Low Stock Price Target: GBX 300
• Potential Upside/Downside: +46.7%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): GBX 5.16
• Trailing P/E Ratio: 39.63
• Forward P/E Ratio: 20.83
• P/E Growth: 5
• Net Income: £11.22 million
• Net Margins: 8.49%
• Pretax Margin: N/A
• Return on Equity: 4.57%
• Return on Assets: 2.35%

Debt

• Debt-to-Equity Ratio: 37.01
• Current Ratio: 8.39
• Quick Ratio: 4.58

Sales & Book Value

• Annual Sales: £132.18 million
• Price / Sales: 3.34
• Cash Flow: GBX 25.97 per share
• Price / Cash Flow: 7.87
• Book Value: GBX 113.37 per share
• Price / Book: 1.80

Miscellaneous

• Outstanding Shares: 215,927,326
• Free Float: N/A
• Market Cap: £441.57 million
• Optionable: Not Optionable
• Beta: 0.74